New combo therapy aims for drug-free remission in CML patients who relapsed before
NCT ID NCT03610971
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 20 times
Summary
This study tests whether adding ruxolitinib to a standard tyrosine kinase inhibitor (TKI) can help people with chronic myeloid leukemia (CML) achieve a lasting remission after stopping all treatment. Participants are adults with CML who previously tried to stop their TKI but relapsed. The goal is to see if the combination allows them to stay in remission without needing lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
David H. Koch Center for Cancer Care at Memorial Sloan Kettering
New York, New York, 10021, United States
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
Emory -Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
Memorial Sloan Kettering - Bergen
Montvale, New Jersey, 07645, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.